MISCELLANEOUS DESIGN — 2307371
Application number
2307371
Registration number
TMA1356152
Type(s)
Design
Category
Trademark
CIPO Status
REGISTERED
TM5 status
LIVE/REGISTRATION/Issued
and Active
The trademark application has been registered with the Office.
Filed
2024-01-29
Registered
2025-10-31
Registration Expiry Date
2035-10-31
Registered Owner
Pfizer Inc.
66 Hudson Boulevard East
New York, NY 10001-2192
UNITED STATES OF AMERICA
Agent
TORYS LLP
SUITE 3000
79 WELLINGTON ST. W.
BOX 270, TD CENTRE
TORONTO
ONTARIO M5K1N2
Documents
Vienna information (Code & Description)
- 15.1.13
- Propellers, ventilators, blowers, turbines, burners -- Note: Includes all kinds of propellers, including those for aircraft or ships.
- 1.15.23
- Vortices, rotary movements, tornadoes -- Note: Not including astronomic orbits (1.13.1), atomic orbits (1.13.1), concentric circles (26.1.4 or 26.1.5) and spirals (26.1.5).
- 26.2.3
- Sectors of circles or ellipses (except 26.2.7)
- 26.2.5
- Joined or intersecting segments or sectors of circles or ellipses
- A 26.2.24
- Segments or sectors of circles or ellipses, semi-circles or semi-ellipses with dark surfaces or parts of surfaces
Goods (Nice class & Statement)
- 5
- (1) Pharmaceutical preparations for the treatment of neurodegenerative, nerve, neuromuscular and brain diseases and disorders, namely muscular dystrophy and ALS; Pharmaceutical preparations for the treatment of the central nervous system, namely brain diseases and central nervous system movement disorders; Pharmaceutical preparations for the treatment of cardiovascular, gastrointestinal and blood diseases and disorders; Pharmaceutical preparations for the treatment of auto-immune diseases and disorders, namely rheumatoid arthritis, lupus, alopecia, ulcerative colitis and Crohn's disease; Pharmaceutical preparations for the treatment of hypertension, menopause symptoms, obesity, stroke, arthritis, migraine, pain and endometriosis; Pharmaceutical preparations for the treatment of cancer; Anti-infectives, anti-inflammatories, anti-fungal and anti-viral agents; Pharmaceutical preparations for the treatment of kidney and liver diseases and disorders; Pharmaceutical preparations for the treatment of bone growth disorders; Pharmaceutical preparations for the treatment of diseases and disorders of the endocrine system, namely growth and thyroid disorders; Pharmaceutical preparations for the treatment of inflammatory diseases, namely inflammatory bowel diseases, inflammatory joint diseases, inflammatory connective tissue diseases, inflammatory muscle diseases and disorders, Pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely cachexia, diabetes, hypoglycemia, obesity, sickle cell disease, non-alcoholic steatohepatitis (NASH) and anemia; Pharmaceutical preparations for the treatment of skin and dermatological diseases and conditions, namely eczema, atopic dermatitis, psoriasis and vitiligo; Human vaccines;
Action History
| Action | Action date | Due date | Comments |
|---|---|---|---|
| Filed | 2024-01-29 | ||
| Created | 2024-01-29 | ||
| Formalized | 2024-01-29 | ||
| Pre-Assessment Letter Sent | 2024-02-08 | Goods or Services Not Acceptable | |
| Search Recorded | 2025-07-07 | ||
| Approved | 2025-07-15 | APPROVED BY PROGRAM EX200M1 | |
| Approval Notice Sent | 2025-07-15 | APPROVED BY PROGRAM EX200M1 | |
| Advertised | 2025-08-13 | Vol.72 Issue 3694 | |
| Registration Pending | 2025-10-31 | ||
| Registered | 2025-10-31 | 2035-10-31 |